Melissa VerHague, PhD

Melissa VerHague, PhD

Melissa VerHague earned her PhD in molecular pathology from Wake Forest University. Her dissertation investigated the impact of apolipoprotein A-IV on triglyceride secretion and lipoprotein particle expansion associated with hepatic steatosis. A native of Buffalo, NY, she joined the NRI as a postdoctoral research associate in September of 2014. Her primary research focus is understanding the role of CD44 in atherosclerosis and metabolic syndrome.